| 1 | [SID56463178] | Active | Potency | 0.0046 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.0046 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 2 | [SID56463178] | Active | Potency | 0.0046 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.0046 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 3 | [SID56463178] | Active | Potency | 0.0046 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.0046 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 4 | [SID56463178] | Active | Potency | 0.0046 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor [AID588790, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.0046 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation with GloSensor | | AID | 588790 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 5 | [SID56463178] | Active | Potency | 0.092 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 6 | [SID56463178] | Active | Potency | 0.092 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 7 | [SID56463178] | Active | Potency | 0.092 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 8 | [SID56463178] | Active | Potency | 0.092 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation [AID588463, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 0.092 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor: Hit Validation | | AID | 588463 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 9 | [SID56463178] | Active | Potency | 7.3078 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 10 | [SID56463178] | Active | Potency | 7.3078 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 11 | [SID56463178] | Active | Potency | 7.3078 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 12 | [SID56463178] | Active | Potency | 7.3078 | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 7.3078 [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 13 | [SID56463178] | Active | Potency | 44.6684 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 14 | [SID56463178] | Active | | | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence [AID686952, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Counterscreen for activators of kallikrein-7 (K7) zymogen: Fluorescence intensity-based biochemical high throughput counterscreen assay for activators that optically interfere with measurement of EDANS-DABCYL fluorescence | | AID | 686952 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 16 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 17 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 18 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 19 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 20 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 21 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 22 | [SID56463178] | Active | | | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 [AID540358, Type: other] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | HTS for Beta-2AR agonists via FAP method, Single Point, Cherry Pick 1 | | AID | 540358 | | BioAssay type | other | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 23 | [SID56463178] | Active | | | Re-confirmation screening for identification of compounds that activate MrgX1 receptor signaling [AID602412, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Re-confirmation screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 602412 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 24 | [SID56463178] | Active | | | Re-confirmation screening for identification of compounds that activate MrgX1 receptor signaling [AID602412, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Re-confirmation screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 602412 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 25 | [SID56463178] | Active | | | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen [AID686949, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 686949 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 26 | [SID56463178] | Active | | | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen [AID686949, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput confirmation assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 686949 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 27 | [SID56463178] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 28 | [SID56463178] | Active | | | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen [AID652039, Type: screening] | KLK7 gene product [Homo sapiens] [gi:21327705] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen | | AID | 652039 | | BioAssay type | screening | | Target | KLK7 gene product [Homo sapiens] [gi:21327705] | | PubMed | | | Data Table |  |
|
| 29 | [SID17405233] | Active | | | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening [AID940, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17405233 | | CID | 656783 | | Outcome | Active | | BioAssay | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening | | AID | 940 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 30 | [SID17405233] | Active | | | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening [AID940, Type: screening] | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17405233 | | CID | 656783 | | Outcome | Active | | BioAssay | Modulators of the EP2 prostaglandin E2 receptor - Primary Screening | | AID | 940 | | BioAssay type | screening | | Target | prostaglandin E receptor 2 (subtype EP2), 53kDa [Homo sapiens] [gi:31881630] | | PubMed | | | Data Table |  |
|
| 31 | [SID56463178] | Active | | | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) [AID493221, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) | | AID | 493221 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 32 | [SID56463178] | Active | | | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) [AID493221, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that inhibit the Choline Transporter (CHT) | | AID | 493221 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 33 | [SID56463178] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 34 | [SID56463178] | Active | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 35 | [SID56463178] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 36 | [SID56463178] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID56463178] | Inactive | EC50 | 0.372 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | EC50 | 0.372 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 38 | [SID56463178] | Inactive | EC50 | 0.372 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | EC50 | 0.372 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 39 | [SID56463178] | Inactive | EC50 | 0.372 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | EC50 | 0.372 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 40 | [SID56463178] | Inactive | EC50 | 0.372 | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 [AID588763, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | EC50 | 0.372 [uM] | | BioAssay | Dose response for HTS for Beta-2AR agonists via FAP method from CP1 | | AID | 588763 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 41 | [SID56463178] | Inactive | Potency | 8.9125 | qHTS for Inhibitors of Glutaminase (GLS) [AID624170, Type: confirmatory] | GLS protein [Homo sapiens] [gi:71051501] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | Potency | 8.9125 [uM] | | BioAssay | qHTS for Inhibitors of Glutaminase (GLS) | | AID | 624170 | | BioAssay type | confirmatory | | Target | GLS protein [Homo sapiens] [gi:71051501] | | PubMed | | | Data Table |  |
|
| 42 | [SID56463178] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 43 | [SID56463178] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 44 | [SID56463178] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 45 | [SID56463178] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 46 | [SID56463178] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 47 | [SID56463178] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 48 | [SID56463178] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 49 | [SID56463178] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|
| 50 | [SID56463178] | Inactive | | | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) [AID652257, Type: screening] | PRMT1 protein [Homo sapiens] [gi:32425330] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56463178 | | CID | 656783 | | Outcome | Inactive | | BioAssay | Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1) | | AID | 652257 | | BioAssay type | screening | | Target | PRMT1 protein [Homo sapiens] [gi:32425330] | | PubMed | | | Data Table |  |
|